UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) | Maryland | | 62-1470956 | | --- | --- | --- | | (State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) | | 222 Robert Rose Drive | | | | Murfreesboro | Tennessee | 37129 | | (Address of principal executive offices) | | (Zip Code) | (615) 890-9100 (Re ...

National Health Investors, Inc. (NYSE:NHI) Q4 2020 Earnings Conference Call February 23, 2021 12:00 PM ET Company Participants Dana Hambly - Director, IR Eric Mendelsohn - President & CEO John Spaid - EVP & CFO Kevin Pascoe - CIO David Travis - CAO Conference Call Participants Daniel Bernstein - Capital One Securities Rich Anderson - SMBC Jordan Sadler - KeyBanc Capital Markets Omotayo Okusanya - Mizuho Securities John Kim - BMO Capital Markets Connor Siversky - Berenberg Operator Greetings, and welcome to ...

Q4 2020 NATIONAL HEALTH INVESTORS Q4 2020 SUPPLEMENTAL TABLE OF CONTENTS 1 Q4 2020 National Health Investors | --- | --- | |-------------------------------------|-------| | COMPANY | | | COMPANY INFORMATION & LEADERSHIP | 02 | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | PORTFOLIO SUMMARY | 04 | | OPERATING PARTNERS | 05 | | EBITDARM LEASE COVERAGE | 06 | | PURCHASE OPTIONS & LEASE MATURITIES | 07 | | INVESTMENTS | | | INVESTMENT RATIONALE | 08 | | RECENT INVESTMENTS | 09 | | CAPITALIZATION | | | CAPITALIZ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number 001-10822 National Health Investors Inc Indicate by check mark if the registrant is not required to file reports ...

National Health Investors, Inc. (NYSE:NHI) Q3 2020 Earnings Conference Call November 10, 2020 12:00 PM ET Company Participants Dana Hambly - Director, IR Eric Mendelsohn - President & CEO John Spaid - EVP, Finance & CFO Kevin Pascoe - CIO Conference Call Participants Daniel Bernstein - Capital One Securities Piljung Kim - BMO Capital Markets Rich Anderson - SMBC Jordan Sadler - KeyBanc Capital Markets Todd Stender - Wells Fargo Securities Aaron Hecht - JMP Securities Omotayo Okusanya - Mizuho Securities Op ...

Q3 2020 NATIONAL HEALTH INVESTORS Q3 2020 SUPPLEMENTAL TABLE OF CONTENTS 1 Q3 2020 National Health Investors | --- | --- | |-------------------------------------|-------| | COMPANY | | | COMPANY INFORMATION & LEADERSHIP | 02 | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | PORTFOLIO SUMMARY | 04 | | | | | OPERATING PARTNERS | 05 | | EBITDARM LEASE COVERAGE | 06 | | PURCHASE OPTIONS & LEASE MATURITIES | 07 | | INVESTMENTS | | | INVESTMENT RATIONALE | 08 | | RECENT INVESTMENTS | 09 | | CAPITALIZATION | | | CAP ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) | Maryland | | 62-1470956 | | --- | --- | --- | | (State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) | | 222 Robert Rose Drive | | | | Murfreesboro | Tennessee | 37129 | | (Address of principal executive offices) | | (Zip Code) | (615) 890-9100 (Re ...

National Health Investors, Inc. (NYSE:NHI) Q2 2020 Earnings Conference Call August 11, 2020 12:00 PM ET Company Participants Dana Hambly - Director of Investor Relations Eric Mendelsohn - President & Chief Executive Officer Kevin Pascoe - Chief Investment Officer John Spaid - Executive Vice President & Chief Financial Officer Donald Thompson - Founder & Chief Executive Officer, Senior Living Communities Conference Call Participants Daniel Bernstein - Capital One Connor Siversky - Berenberg John Kim - BMO Ca ...

Q2 2020 NATIONAL HEALTH INVESTORS Q2 2020 SUPPLEMENTAL TABLE OF CONTENTS 1 Q2 2020 National Health Investors | --- | --- | |---------------------------------------------|-------| | COMPANY \n COMPANY INFORMATION & LEADERSHIP | 02 | | PORTFOLIO | | | PORTFOLIO OVERVIEW | 03 | | PORTFOLIO SUMMARY | 04 | | OPERATING PARTNERS | 05 | | EBITDARM LEASE COVERAGE | 06 | | PURCHASE OPTIONS & LEASE MATURITIES | 07 | | INVESTMENTS | | | INVESTMENT RATIONALE | 08 | | RECENT INVESTMENTS | 09 | | CAPITALIZATION | | | CAPI ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 001-10822 National Health Investors Inc (Exact name of registrant as specified in its charter) | Maryland | | 62-1470956 | | --- | --- | --- | | (State or other jurisdiction of incorporation or | | | | organization) | | (I.R.S. Employer Identification No.) | | 222 Robert Rose Drive | | | | Murfreesboro | Tennessee | 37129 | | (Address of principal executive offices) | | (Zip Code) | (615) 890- ...